查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2023552

大腸直腸癌篩檢市場分析及預測（至2035年）：按類型、服務、技術、應用和最終用戶分類

Colorectal Cancer Screening Market Analysis and Forecast to 2035: Type, Services, Technology, Application, End User
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球大腸癌篩檢市場預計將從2025年的178億美元成長到2035年的312億美元，複合年成長率（CAGR）為5.6%。篩檢量龐大，每年在包括美國疾病管制與預防中心（CDC）在內的機構支持的計畫下，進行數百萬例篩檢。檢測方法多種多樣，從非侵入性糞便檢驗到先進的大腸鏡檢查。價格差異顯著，糞便檢驗費用在20美元至150美元之間，而大腸鏡檢查費用則在1000美元至3000美元之間。 Exact Sciences等公司提供先進的篩檢解決方案。雖然價格受技術類型、醫療基礎設施和報銷政策的影響，但由於公眾意識的提高和政府措施的推動，全球篩檢率持續上升。

大腸直腸癌篩檢市場的「適應性」細分市場主要由早期檢測驅動，早期檢測在提高生存率和降低治療成本方面發揮著至關重要的作用，因此佔市場主導地位。大腸鏡檢查和糞便檢驗等篩檢方法被廣泛用於癌症的早期發現和癌前息肉的識別。預防性應用也十分重要，因為定期篩檢有助於透過及時介入降低疾病發生率。全球大腸直腸癌負擔的日益加重，以及公眾意識的提高和政府主導的篩檢舉措，正有力地推動著該細分市場的成長。

市場區隔
類型 大便潛血試驗（FOBT）、糞便DNA檢測、乙狀結腸鏡檢查、大腸鏡檢查、CT結腸成像
服務 篩檢服務、診斷服務、病理檢測服務
科技 免疫化學、癒創木脂法、DNA法、診斷影像
目的 早期發現、診斷和後續觀察。
最終用戶 醫院、診斷檢查室、門診手術中心、專科診所

在終端用戶領域，醫院是大腸直腸癌篩檢解決方案的主要採用者，其次是診斷檢查室。醫院之所以佔主導地位，是因為它們擁有先進的基礎設施、專業的醫護人員以及全面的癌症治療服務。診斷實驗室的主導日益凸顯，這得益於診斷服務外包趨勢的不斷成長以及對具成本效益檢測方案需求的持續增加。此外，醫療基礎設施的擴建，尤其是在新興國家，以及全國性篩檢計畫的推廣，都顯著推動了醫院和診斷實驗室的業務成長。

區域概覽

北美在結直腸癌篩檢市場佔最大佔有率，這得益於其民眾對早期癌症檢測的高度重視、完善的醫療基礎設施以及預防性篩檢計畫的廣泛實施。美國憑藉完善的篩檢指南（建議常規大腸鏡檢查、糞便檢驗以及新型非侵入性篩檢方法）鞏固了其區域領先地位。優惠的報銷政策和不斷擴大的保險覆蓋範圍進一步鼓勵了全體民眾參與篩檢。此外，先進的診斷技術和許多領先醫療機構的鼎力支持也為早期診斷提供了有力保障。持續進行的政府主導的宣傳宣傳活動以及高額的醫療費用支出，也顯著鞏固了北美在全球大腸癌篩檢市場的主導地位。

由於癌症發生率上升、醫療基礎設施改善以及早期檢測意識增強，亞太地區預計將成為大腸癌篩檢市場複合年成長率最高的地區。中國、印度、日本和韓國等國家正在實施全國篩檢計劃，以應對日益嚴重的大腸癌負擔。診斷設施的普及和醫療保健支出的成長正在推動市場成長。此外，都市化加快、飲食習慣改變以及人口老化也加劇了疾病的流行。政府為改善預防醫學所採取的措施以及與全球診斷公司的合作，正在進一步加速該地區大腸癌篩檢方案的普及。

主要趨勢和促進因素

大腸直腸癌發生率上升以及人們對早期診斷意識的提高

大腸直腸癌篩檢市場的主要促進因素是全球大腸癌發生率的不斷上升，尤其是在老年人和有文明病風險因素的人群中。缺乏運動、不健康飲食和肥胖加劇了全球疾病負擔。這促使人們更加重視早期發現和預防性篩檢的重要性。各國政府和醫療機構正積極推廣篩檢項目，以期透過早期診斷提高存活率。糞便DNA檢測和血液生物標記等非侵入性篩檢技術的進步，進一步提高了篩檢參與率，並推動了市場成長。

非侵入式和人工智慧驅動的篩檢技術的擴展

大腸直腸癌篩檢市場的一大機會在於非侵入性人工智慧診斷技術的開發和應用。諸如血液檢測、糞便DNA分析以及人工智慧輔助解讀大腸鏡檢查觀察等創新技術，正在圖篩檢的準確性、便利性和患者參與率。這些技術減少了侵入性檢查的需求，並促進了更廣泛人群的篩檢。此外，人工智慧（AI）和機器學習的整合能夠更早預測風險並提高診斷效率。遠端醫療服務的擴展和家用篩檢盒的普及進一步提升了篩檢的可近性。對精準腫瘤學和個人化篩檢方法的持續投入，正為全球市場相關人員創造巨大的長期成長機會。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 大便潛血試驗（FOBT）
    • 糞便DNA檢測
    • 乙狀結腸鏡檢查
    • 大腸鏡檢查
    • CT造影
    • 其他
  • 市場規模及預測：依產品分類
    • 檢測套組
    • 裝置
    • 試劑
    • 其他
  • 市場規模及預測：依服務分類
    • 篩檢服務
    • 診斷服務
    • 病理檢測服務
    • 其他
  • 市場規模及預測：依技術分類
    • 免疫化學
    • 癒創木
    • 基於DNA的
    • 診斷影像
    • 其他
  • 市場規模及預測：依組件分類
    • 消耗品
    • 軟體
    • 硬體
    • 其他
  • 市場規模及預測：依應用領域分類
    • 早期檢測
    • 診斷
    • 監測
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷檢測實驗室
    • 門診手術中心
    • 專科診所
    • 其他
  • 市場規模及預測：依設備分類
    • 內視鏡
    • CT掃描儀
    • 其他
  • 市場規模及預測：依製程分類
    • 篩檢
    • 診斷
    • 監測
    • 其他
  • 市場規模及預測：按解決方案分類
    • 院內檢測
    • 外包檢驗
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Exact Sciences
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Quest Diagnostics
  • Hologic
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Fujifilm Holdings
  • Sysmex Corporation
  • Becton Dickinson and Company
  • Illumina
  • Qiagen
  • Agilent Technologies
  • Danaher Corporation
  • PerkinElmer
  • Genomic Health
  • Myriad Genetics
  • Guardant Health
  • Natera

第9章 關於我們

簡介目錄
Product Code: GIS34511

The global colorectal cancer screening market is projected to grow from $17.8 billion in 2025 to $31.2 billion by 2035, at a compound annual growth rate (CAGR) of 5.6%. Screening volumes are substantial, with millions of procedures conducted annually under programs supported by organizations like Centers for Disease Control and Prevention. Tests range from non-invasive stool-based kits to advanced colonoscopy procedures. Pricing varies widely, with stool tests costing USD 20-150, while colonoscopies range from USD 1,000 to USD 3,000. Companies such as Exact Sciences offer advanced screening solutions. Pricing is influenced by technology type, healthcare infrastructure, and reimbursement policies, while increasing awareness and government initiatives continue to boost screening rates globally.

The Application segment in the colorectal cancer screening market is primarily driven by early detection, which dominates due to its critical role in improving survival rates and reducing treatment costs. Screening methods such as colonoscopy and stool-based tests are widely used to detect cancer at an early stage or identify precancerous polyps. Preventive applications are also significant, as regular screening helps in reducing disease incidence through timely intervention. The rising global burden of colorectal cancer, along with increasing awareness and government-led screening initiatives, is strongly supporting growth in this segment.

Market Segmentation
TypeFecal Occult Blood Test (FOBT), Stool DNA Test, Flexible Sigmoidoscopy, Colonoscopy, CT Colonography
ServicesScreening Services, Diagnostic Services, Pathology Services
TechnologyImmunochemical, Guaiac, DNA-Based, Imaging
ApplicationEarly Detection, Diagnosis, Monitoring
End UserHospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Specialty Clinics

The End User segment is led by hospitals, followed by diagnostic laboratories, as key adopters of colorectal cancer screening solutions. Hospitals dominate due to their advanced infrastructure, availability of skilled professionals, and comprehensive cancer care services. Diagnostic laboratories are gaining traction with the increasing trend of outsourcing diagnostic services and the growing demand for cost-effective testing solutions. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, and the increasing implementation of national screening programs are driving significant growth across both hospitals and diagnostic laboratories.

Geographical Overview

North America holds the largest market share in the Colorectal Cancer Screening Market due to high awareness of early cancer detection, strong healthcare infrastructure, and widespread adoption of preventive screening programs. The United States drives regional dominance with established screening guidelines recommending regular colonoscopy, stool-based tests, and emerging non-invasive screening methods. Favorable reimbursement policies and insurance coverage further encourage population-wide screening participation. Additionally, advanced diagnostic technologies and strong presence of leading healthcare providers support early diagnosis initiatives. Continuous government-led awareness campaigns and high healthcare spending significantly contribute to North America maintaining the leading position in the global colorectal cancer screening market.

Asia Pacific is expected to register the highest CAGR in the Colorectal Cancer Screening Market due to rising cancer incidence, improving healthcare infrastructure, and growing awareness of early detection. Countries such as China, India, Japan, and South Korea are increasingly adopting national screening programs to address the growing burden of colorectal cancer. Expanding access to diagnostic facilities and increasing healthcare expenditure are supporting market growth. Additionally, rising urbanization, changing dietary habits, and aging populations are contributing to higher disease prevalence. Government initiatives to improve preventive healthcare and partnerships with global diagnostic companies further accelerate the adoption of colorectal cancer screening solutions in the region.

Key Trends and Drivers

Rising prevalence of colorectal cancer and increasing awareness of early diagnosis

A key driver of the Colorectal Cancer Screening Market is the increasing global incidence of colorectal cancer, particularly among aging populations and individuals with lifestyle-related risk factors. Sedentary habits, unhealthy diets, and obesity have contributed to a growing disease burden worldwide. This has led to heightened awareness about the importance of early detection and preventive screening. Governments and healthcare organizations are actively promoting screening programs to improve survival rates through early diagnosis. Advancements in non-invasive screening technologies, such as stool DNA tests and blood-based biomarkers, are further encouraging higher participation rates and driving market growth.

Expansion of non-invasive and AI-enabled screening technologies

A major opportunity in the Colorectal Cancer Screening Market lies in the development and adoption of non-invasive and AI-enabled diagnostic technologies. Innovations such as blood-based tests, stool DNA analysis, and AI-assisted colonoscopy interpretation are improving accuracy, convenience, and patient compliance. These technologies reduce the need for invasive procedures, encouraging wider population screening. Additionally, integration of artificial intelligence and machine learning enables early risk prediction and improved diagnostic efficiency. Expanding telehealth services and at-home screening kits further enhance accessibility. Growing investment in precision oncology and personalized screening approaches creates significant long-term growth opportunities for market players globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Device
  • 2.9 Key Market Highlights by Process
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Fecal Occult Blood Test (FOBT)
    • 4.1.2 Stool DNA Test
    • 4.1.3 Flexible Sigmoidoscopy
    • 4.1.4 Colonoscopy
    • 4.1.5 CT Colonography
    • 4.1.6 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Test Kits
    • 4.2.2 Instruments
    • 4.2.3 Reagents
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Screening Services
    • 4.3.2 Diagnostic Services
    • 4.3.3 Pathology Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Immunochemical
    • 4.4.2 Guaiac
    • 4.4.3 DNA-Based
    • 4.4.4 Imaging
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Consumables
    • 4.5.2 Software
    • 4.5.3 Hardware
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Early Detection
    • 4.6.2 Diagnosis
    • 4.6.3 Monitoring
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Laboratories
    • 4.7.3 Ambulatory Surgical Centers
    • 4.7.4 Specialty Clinics
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Device (2020-2035)
    • 4.8.1 Endoscopes
    • 4.8.2 CT Scanners
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Process (2020-2035)
    • 4.9.1 Screening
    • 4.9.2 Diagnosis
    • 4.9.3 Monitoring
    • 4.9.4 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 In-House Testing
    • 4.10.2 Outsourced Testing
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Device
      • 5.2.1.9 Process
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Device
      • 5.2.2.9 Process
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Device
      • 5.2.3.9 Process
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Device
      • 5.3.1.9 Process
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Device
      • 5.3.2.9 Process
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Device
      • 5.3.3.9 Process
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Device
      • 5.4.1.9 Process
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Device
      • 5.4.2.9 Process
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Device
      • 5.4.3.9 Process
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Device
      • 5.4.4.9 Process
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Device
      • 5.4.5.9 Process
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Device
      • 5.4.6.9 Process
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Device
      • 5.4.7.9 Process
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Device
      • 5.5.1.9 Process
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Device
      • 5.5.2.9 Process
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Device
      • 5.5.3.9 Process
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Device
      • 5.5.4.9 Process
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Device
      • 5.5.5.9 Process
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Device
      • 5.5.6.9 Process
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Device
      • 5.6.1.9 Process
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Device
      • 5.6.2.9 Process
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Device
      • 5.6.3.9 Process
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Device
      • 5.6.4.9 Process
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Device
      • 5.6.5.9 Process
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Exact Sciences
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Roche Diagnostics
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Abbott Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Siemens Healthineers
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Quest Diagnostics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Hologic
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Thermo Fisher Scientific
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Bio-Rad Laboratories
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Fujifilm Holdings
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Sysmex Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Becton Dickinson and Company
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Illumina
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Qiagen
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Agilent Technologies
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Danaher Corporation
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 PerkinElmer
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Genomic Health
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Myriad Genetics
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Guardant Health
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Natera
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us